
Small Animals
| Reference Ranges | Canine | 0-<30 IU/L/l | Feline | 10-25 IU/L/l |
ALT is almost liver specific in dogs and cats. It is found in the cytoplasm of hepatocytes and is released into the blood during changes in cell membrane permeability or necrosis. Its superficial location means that a relatively mild insult ,e.g. hypoxia, may lead to increased serum levels. Half life is about 60 hours in the dog and shorter in the cat.. In chronic hepatic disease with loss of functional mass levels may be deceptively low. In acute disease a rapid decline in levels may be a favourable sign. Recent work has demonstrated that ALT levels may also increase due to increased synthesis and release by healthy hepatocytes.
ELEVATED LEVELS
Secondary hepatopathiesCopper storage
disease
Hyperthyroidism (cat)
Hyperadrenocorticism
Diabetes mellitus
Glucocorticoid therapy
Hypothyroidism (dog)
Post hepatic obstructive jaundice
ALT is of no value in the horse due to its low liver activity.
COMPLIEMENTARY TESTS
Plasma ALT activity is usually determined
in conjunction with other tests of hepatocellular damage or hepatic function
specifically AP, AST, GGT, GLDH and Bile Acids.
Top
Small Animals
| Reference Ranges | Canine | 300-2000 IU/L/l | Feline | 0-1500 IU/L/l |
Only alpha amylase is found in animals. Pancreas, liver and small intestine are the main sources of serum amylase. In the healthy dogs and cats most amylase is derived from the small intestine.
ELEVATED LEVELS
COMPLEMENTARY TESTS
When elevated, serum lipase levels
should also be determined.
Top
AP isoenzymes are found in a variety of tissues including intestine, liver, bone, placenta, kidney and leukocytes. Unlike ALT, AST and GLDH, increased serum levels of AP are due to increased synthesis of the enzyme.
Small Animals
| Reference rRanges | Canine | 0-<100 IU/L/l (adult) | Feline | 0-40 IU/L/l |
Hepatic AP isoenzyme has a half life of 3 days in the dog and only 5.8 hours in the cat. Increases are usually of greater magnitude in dogs but of greater significance in cats. Other isoenzymes have a half life of only minutes so can effectively be ignored. Steroid induced AP can be determined in dogs but is of questionable value as a diagnostic aid. AP levels will remain elevated during hepatic repair and this is not a poor prognostic indicator as AP is released by healthy hepatocytes.
ELEVATED LEVELS
Plasma AP activity is usually determined in conjunction with other tests of hepatocellular damage or hepatic function, specifically ALT, AST, GGT, GLDH and Bile Acids.
Equine
| Reference Range | Equine | 0-145 IU/L/l |
In the horse a significant amount of AP intestinal isoenzyme is released from the intestinal mucosa and this can be distinguished from total AP by performing an intestinal AP assay. Elevated AP is a useful indicator of cholestasis.
ELEVATED LEVELS
Plasma AP activity is usually determined
in conjunction with other tests of hepaticocellular function and damage
or hepatic function, specifically AST, GGT, GLDH and Bile Acids.
Top
AST occurs in the liver, erythrocytes and all types of muscle. It is found in the both the cytoplasm and mitochondria of cells hepatocytes and is released into the blood due to hepatucellular damage and during changes in cell membrane permeability or necrosis. Half life is about 12 hours in the dog, less in cats and 7 to 8 days in horses
Small Animals
| Reference Ranges | Canine | 0-< 30 IU/L | Feline | 10 - 30 IU/L/l |
ELEVATED LEVELS
Plasma AST activity is usually determined in conjunction with other tests of hepatocellular damage and skeletal muscle damage eg. specifically AP, ALTALT GGT, and GLDH for hepatocellular damage and CK for skeletal muscle damage.
Equine
| Reference Range : | Equine | 0 - 250 IU/L/l |
ELEVATED LEVELS.
Plasma AST activity should be assessed
along with GLDH and GGT (hepatic disease) and CK (azoturia). Following
an episode of azoturia, AST levels peak at 24 - 48 hours and decline slowly
over 7 to 10 days returning to baseline levels by 10-21 days. This contrasts
with CK which peaks after 6-122 hours and declines rapidly over 2 days
returning to baseline levels. by 3-4 days.
Top
Bilirubin is formed from the metabolism of haem groups in the liver, spleen and bone marrow and is taken up and conjugated by hepatocytes before excretion in the bile.
Small Animals
| Total bilirubin | Canine | 0-< 5 m mol umol/L/ll | Feline | 0 - 4.0 m umol/L/l |
| Direct bilirubin | Canine | 0-<1.7 um mol/L/l | Feline | 0 - 1.5 um mol/L/l |
ELEVATED LEVELS
The differentiation of total serum bilirubin into direct acting (conjugated) and indirect acting (unconjugated) bilirubin is routinely performed but is of strictly limited diagnostic value. As a rule of thumb, 90% of bilirubin must be either direct acting or indirect acting before it is of diagnostic value (direct acting indicating biliary tract obstruction and indirect acting indicating haemolysis). A haemogram should be used to rule out haemolysis. Bile acids will be elevated due to loss of hepatocellular mass or biliary obstruction but not due to haemolysis. Marked increases in AP and GGT will be seen with post hepatic cholestasis.
Equine
|
|
||
| Total bilirubin | Equine | 10.0 - 40.0 um mol/L/l |
| Direct bilirubin | Equine | 4.2 - 14.8 um mol/L/l |
ELEVATED LEVELS
In contrast to small animals, only
modest increases in direct acting bilirubin are seen in either liver failure
or in cholestasis. Where direct acting bilirubin forms 25 - 50% of the
total bilirubin , this indicates significant cholestasis.
Top
Bile acids are synthesised in the liver from cholesterol and are conjugated with taurine or glycine before excretion as bile salts into the bile. Bacterial action in the intestine deconjugates some to bile acids and converts the rest to secondary bile salts. These products ienter the portal circulation and are extracted and recycled by the hepatocytes. It is those bile acids not extracted which are measured in the peripheral blood.
Small Animals
|
|
||||
| Fasted | Canine | <0- 1030 mm mol/L/l | Feline | <0-2 5 mm mol/L |
| 2 hours post feeding | Canine | < 0-350 mm mol/L/l | Feline | < 0-2530 mm mol/L/l |
The measurement of fasting bile acid levels is at least as sensitive as either the bromsulphthalein clearance test or the ammonium tolerance test as a measure ofr hepatic function. Pre and post feeding bile acids are measured on a 12 hour fasted sample and a sample taken 2 hours post feeding (canned food). This is more sensitive than a single fasted sample and is recommended where the fasted result is less than 10 x normal (dog) or < 5x normal (cat)..
ELEVATED LEVELS
Tests for cholestasis (AP, GGT and bilirubin) and hepatic function (albumin and urea) are indicated along with tests for hepatocellular damage (ALT, AST and GLDH).
Equine
| Reference Range : | Equine | < 0-20 mm mol/L/l. |
As in the dog and cat, bile acids are conjugated largely with taurine. The rate of enterohepatic circulation is fairly constant so fasting is not required before sampling.
ELEVATED LEVELS
Tests for cholestasis (AP, GGT and
bilirubin) and hepatocellular damage (AST and GLDH). Albumin is less useful
as an indicator of hepatic insufficiency in the horse than in small animals
due to its long half life (hypoalbuminaemia only seen in advanced liver
failure).
Top
Calcium is an essential mineral which is involved in many body systems. These include the skeleton, enzyme activation, muscle metabolism, blood coagulation and osmoregulation. In the blood calcium exists as 50% ionisedionized, 40% protein bound and 10% complexed with anions such as citrate and phosphate. Only ionisedionized calcium is biologically active in bone formation, neuromuscular activity, cellular biochemical processes and blood coagulation. Factors governing the total plasma concentration are complex and include interaction with other chemical moieties, proteins and hormones. Calcium, phosphorous and albumin metabolism are interdependent. Serum calcium values must be adjusted to take account of low albumin levels. This calculated value is shown on the report.
Small Animals
| Reference rRanges | Canine | 2.3 - 3.0 mmol/L/l | Feline | 2.0 - 2.8 mmol/L/l |
Homeostatic mechanisms in small animals
maintain plasma calcium levels within tight reference ranges. Elevated
and low levels are generally significant.
| ELEVATED LEVELS | LOW LEVELS |
| Hypercalcaemia | Hypocalcaemia |
| Lymphoproliferative disease(dogs) | Hypoalbuminaemia |
| Hypoadrenocorticism (dogs) | Malabsorption |
| Malignant neoplasia | Acute pancreatitis |
| Primary renal failure (CRF or familial) | Renal secondary hhyperparathyroidism |
| Primary hyperparathyroidism | Eclampsia |
| Hypervitaminosis D | Primary hypoparathyroidism |
| Post thyroidectomy (cats) | |
| Nutritional secondary hyperparathyroidismHyperthyroidism (cats) | |
| Ethylene glycol poisoning Nutritional secondary hyperparathyroidism | |
| Acute renal failure (especially post renal obstruction)Ethylene glycol poisoning | |
| Glucocorticoid therapy Acute renal failure (especially post renal obstruction) |
COMPLEMENTARY TESTS
PTH assay (primary hyperparathyroidism), serum electrolytes and ACTH stimulation test (hypoadrenocorticism), urea and creatinine (primary renal failure, hypoadrenocorticism, acute tubular necrosis secondary to hypercalcaemia), amylase and lipase (pancreatitis), albumin (hypoalbuminaemia), T4 (hyperthyroidism), phosphorus (primary hyperparathyroidism and malignant neoplasia).
Equine
| Reference Range : | Equine | 2.6 - 3.9 mmol/L/l |
Homeostatic mechanisms are efficient
in maintaining plasma calcium levels within the reference range. Elevated
and low levels are therefore significant.
| ELEVATED LEVELS | LOW LEVELS | |||
| Hypercalcaemia | Hypocalcaemia | |||
| Chronic renal failure | Lactation tetany | |||
| Malignant neoplasia | Transit tetany | |||
| Vit D toxicosis | Acute renal failure | |||
| Primary hyperparathyroidism | Abdominal crisis | |||
| Nutritional secondary | Primary hypoparathyroidism | |||
| Hyperparathyroidism | Acute pancreatitis | |||
| Hypoalbuminaemia | ||||
COMPLEMENTARY TESTS
Albumin and phosphorous determinations
should always be included. Differentiation of diseases causing abnormal
calcium levels can be facilitated by the determination of fractional clearance
of calcium in blood and urine.
Top
Equine
| Reference Range : | Equine | 89 - 106 mmol/L/l |
Chloride is present in highest concentrations
in the ECF and tends to accompany sodium movement by passive diffusion.
| ELEVATED LEVELS | LOW LEVELS |
| Hyperchloraemia | Hypochloraemia |
| Dehydration | Gastro-intestinal loss (higher bowel obstruction) |
| Acidosis | Low salt diet |
| Respiratory alkalosis | Respiratory acidosis. |
| Renal dysfunction | Oesophageal obstruction |
COMPLEMENTARY TESTS
In equines the calculation of urine clearance ratios will assist interpretation of serum electrolyte and mineral levels.
Cholesterol is produced in the liver and acquired by diet. Plasma cholesterol occurs at high concentration in the esterified form and at much lower concentration in the free form, and tthese are measured together as total cholesterol. Cholesterol is esterified in the liver and is the precursor of steroid hormones. Cholesterol is also utilisedbroken down in the liver to synthesise bile acids. and eliminated via Surplus cholesterol is excreted via the bile. duct.
Small Animals
| Reference Rranges | Canine | 3.8 - 7.9 mmol/L/l | Feline | 2.0 - 3.9 mmol/L/l |
| ELEVATED LEVELS | LOW LEVELS |
| High fat diet/post prandial | Hepatic failure |
| Hypothyroidism | Primidone therapy (dogs) |
| Nephrotic Syndrome | Low fat diet/ malabsorption/ EPI |
| Cholestatic disorders | |
| Diabetes mellitus | |
| Acute pancreatitis | |
| Hyperadrenocorticism | |
| Glucocorticoid therapy | |
| Idiopathic hyperlipidaemias |
COMPLEMENTARY TESTS
Triglyceride levels as both triglycerides and cholesterol combine in lipoproteins. Triglyceride levels determine visible lipaemia.
Equine
| Reference Range | Equine | 2.3 - 3.6 mmol/L/l |
| ELEVATED LEVELS | LOW LEVELS |
| Cholestasis | Liver disease |
| Hypothyroidism | Sepsis |
| Starvation |
Also known as creatine phosphokinase (CPK). CK occurs in high levels in skeletal muscle, cardiac muscle and brain tissue though only skeletal and cardiac muscle are of major significance. The enzyme is essential for the rapid conversion of ADP to ATP to release energy for muscle contraction. Thus if muscle tissue is disrupted the enzyme is released into the blood stream and is readily detected.
Small Animals
| Reference rRanges | Canine | <0 - 300 IU/L/l | Feline | 0 - 300 IU/L/l |
Experience has shown that levels can rise slightly with muscular exertion alone but where pathological conditions exist the levels are usually very high. Increase associated with cardiomyopathies is are much less than with rhabdomyopathies in small animals. Generally, re-sampling in 2 to 3 days is recommended to exclude trauma as a cause of elevated levels.
ELEVATED LEVELS
Usually determined along with AST to assess possible muscle damage. A TRH stimulation test is indicated if hypothyroidism is suspected.
Equine.
| Reference Range : | Equine | 0 -100 IU/L/l |
ELEVATED LEVELS
Usually determined along with AST.
Following an episode of azoturia, CK peaks after 6 - 12 hours and declines
rapidly over 2 days returning to baseline levels by 3 - 4 days. AST peaks
after at 24-48 hours and declines slowly over 7 to 10 days returning to
baseline levels by 10 -21 days..
Top
Creatinine is produced at a steady rate due to muscle catabolism and is not reabsorbed by the kidney tubules after filtration. Its measurement provides an indirect assessment of the glomerular filtration rate (GFR). The relationship between the GFR and creatinine excretion are is not linear; with creatinine levels of less than 180 nmol/L/l (in the dog) there may be up to three quarters of the nephrons lost, thereafter even small losses may result in substantial increases in creatinine levels. Unlike urea it is not markedly affected by diet or any aspect of liver function and therefore the test is more specific for renal dysfunction.
Small Animals
| Reference rRanges | Canine | 0 - <106 um mol/L/l | Feline | 40 - 180 um mol/L/l |
ELEVATED LEVELS
Urea (azotaemia), phosphorus and urine specific gravity (see Urea).
Equine.
| Reference Range | Equine | 87 - 163 umol/L/l |
Urea levels are influenced to a large extent by diet in horses making creatinine a more suitable guide to the GFR.
ELEVATED LEVELS
Urea (azotaemia), phosphorus, urine
clearance ratios (renal dysfunction).
Top
Serum fructosamine measures the glycation of serum proteins (principally albumin) and is an accurate measure of the average serum glucose concentration over 1 to 2 weeks (dogs) or 1 to 3 weeks (cats).
Small Animals
| Reference Ranges | Canine | 240 - 350 umol/L | Feline | 130 - 280 mmol/L |
ELEVATED LEVELS
Plasma glucose
Top
The highest concentration of GGT is found in the renal tubule cells but, as it is excreted in the urine, levels do not rise in response to renal damage. Circulating enzyme is considered to originate from the liver (biliary endothelial cells and hepatocytes).
Small Animals
| Reference rRanges | Canine | 0 - 10 IU/L/l | Feline | <0 - 5 IU/L/l |
GGT is considered a specific indicator of hepatobiliary disease in the cat.
ELEVATED LEVELS.
AP (increases in AP largely parallel those in GGT). ALT and GLDH (hepatocellular damage), bile acids (hepatic function) and bilirubin (cholestasis).
Equine
| Reference Range : | Equine | 0 - 41 IU/L/l |
As in cats, GGT is considered a specific indicator of both acute and chronic hepatobiliary disease. GGT has a long half life and levels may remain elevated after the pathology resolves.
ELEVATED LEVELS
AST and GLDH (hepatocellular damage),
bile acids (hepatic function) and bilirubin (cholestasis) (bilirubin).
Top
Practically liver specific, this enzyme is localised almost exclusively in the mitochondria of hepatocytes. It is generally considered that a severe insult is required to bring about its release and it is therefore not a sensitive general marker for hepatic disease (but see below).
Small Animals.
| Reference Ranges | Canine | 0 -< 9.0 IU/L/l | Feline | 0 - 6.0 IU/L/l |
GLDH has been demonstrated to be a sensitive marker of hepatocellular necrosis in the dog irrespective of its severity. It is considered to be at least as specific as ALT as a marker of hepatic disease in the dog.
ELEVATED LEVELS
ALT and AST (hepatocellular damage) and bile acids (hepatic function).
Equine
| Reference Range | 0 - 9.0 IU/L/l |
GLDH has a relatively short half life in the horse (12 - 14 hours) compared to LDH, AST and GGT. Elevated levels therefore indicate active hepatocellular damage.
ELEVATED LEVELS
AST,LDH and GGT (hepatocellular
damage) and bile acids (hepatic function).
Top
Glucose is the source of energy in the body and is regulated by insulin and glucagon. Glucose passes freely through the renal glomeruli and is totally reabsorbed in the renal tubules. As plasma glucose levels rise this mechanism is saturated and the "renal threshold" exceeded, glucose then appears in the urine.
Small Animals
|
|
|||
| Canine | 3.0 - 5.5 mmol/L/l (fasting) | Feline | 4.3 - 6.6 mmol/L/l (fasting) |
Renal thresholds for the dog and cat
are approximately 10 mmol/L/l and 16 mmol/L/l respectively.
| ELEVATED LEVELS | LOW LEVELS |
| Hyperglycaemia | Hypoglycaemia |
| Diabetes mellitus | Hepatic insufficiency |
| Stress (cats) | Insulinoma |
| Steroid therapy | Insulin therapy |
| Post prandial | Hypoadrenocorticism |
| Hyperadrenocorticism | Starvation (especially neonates) |
| Acute pancreatitis | Septicaemia |
| Megoestrol acetate therapy | |
| Acromegally (especially cats) |
COMPLEMENTARY TESTS
Urine glucose. (Glycosuria in the absence of hyperglycaemia indicates a primary renal problem or poisoning),. Fructosamine (diabetes mellitus, stress hyperglycaemia), ACTH stimulation test (hyperadrenocorticism, hypoadrenocorticism), IGF1 (acromegally), amylase and lipase (pancreatitis), insulin (insulinoma), bile acids (hepatic insufficiency).
Equine
| Reference Range | Equine | 3.4 - 5.9 mmol/L/l |
| ELEVATED LEVELS | LOW LEVELS |
| Hyperglycaemia | Hypoglycaemia |
| Post prandial | Insulinoma |
| Pituitary adenoma | Malabsorption |
| Post exercise | Scouring |
| Pancreatic destruction (rare) | |
| Obesity (non- insulin dependant d. mellitus) | |
| Pregnancy |
COMPLEMENTARY TESTS
Oral or i/v glucose tolerance test
(diabetes mellitus). TRH response test (pituitary adenoma).
Top
Equine
| Reference Range : | Equine | 0-150 IU/L/l |
ELEVATED LEVELS
Protein electrophoresis (when hyperglobulinaemia
present)
Top
This enzyme is present in large amounts in all organs and tissues (including red blood cells). It is found in the cell cytoplasm and is released into the blood during changes in cell membrane permeability or necrosis. Five isoenzymes are recognised.
Small Animals
| Reference Ranges | Canine | 0 -< 150 IU/L/l | Feline | 0 - 150 IU/L/l |
ELEVATED LEVELS
Increases in LDH activity are not organ specific. Isoenzyme analysis is not performed in small animals.
Equine
| Reference Range | Equine | 76 - 409 IU/L/l |
ELEVATED LEVELS
Isoenzyme analysis may be indicated
when total LDH activity is elevated in order to localise the affected organ.
Top
Small Animals
| Reference Ranges | Canine | 0 -< 500 IU/L/l | Feline | 0 - 250 IU/L/l |
ELEVATED LEVELS
Amylase (pancreatitis), urea and
creatinine (renal failure), ALT, GLDH (hepatocellular damage).
Top
Serum phosphorus is primarily regulated by the kidney through the action of parathyroid hormone . Abnormal levels are caused by variations in dietary intake, decreased renal excretion and the hormonal imbalances that affect serum calcium.
Small Animals
| Reference Ranges | Canine | 0.9 - 1.6 mmol/L/l | Feline | 0.81 - 1.61 mmol/L/l (< 2yr) |
| ELEVATED LEVELS | LOW LEVELS |
| Prerenal, renal and post renal azotemia (see Urea) | Malignant neoplasia |
| Young animals (< 1yr) | Glucocorticoid therapy |
| Hyperthyroidism (cats) | Primary hyperparathyroidism |
| Nutritional secondary hyperparathyroidism | Oral phosphate-binding agents |
| Primary hypoparathyroidism | Osteomalacia |
| Hypervitaminosis D | Hyperadrenocorticism |
| Tissue necrosis | Hypovitaminosis D |
| OsseousOsseus neoplasia | Renal tubular defects |
COMPLEMENTARY TESTS
Calcium, urea and creatinine. Urine specific gravity (azotaemia), T4 (hyperthyroidism), PTH (primary hyperparathyroidism).
Equine
| Reference Range | Equine | 0.8 - 1.8 mmol/L/l |
Serum phosphate levels fall readily
after exercise therefore samples should be taken at rest.
| ELEVATED LEVELS | LOW LEVELS |
| Post prandial | Primary hyperparathyroidism |
| Hypoparathyroidism | Scouring |
| Vit D excess | Vit D deficiency |
| Nutritional secondary hyperparathyroidism | Chronic renal failure |
COMPLEMENTARY TESTS
Urea and creatinine (renal failure). Urine clearance ratios (renal
failure, primary hyperparathyroidism, nutritional secondary hyperparathyroidism).
Top
Small Animals
| Reference Ranges | Canine | 3.5 - 5.6 mmol/L/l | Feline | 3.5 - 5.5 mmol/L/l |
Plasma potassium levels are not always
a good indicator of intracellular levels; in acidosis the exchange of H+
and K+ ions leads to the depletion of intracellular potassium and elevated
plasma potassium. The converse occurs in alkalosis. Hypokalaemia may lead
to neurological, muscular and cardiac signs. Hypokalaemia is of particular
significance in the cat. In most cases, hyperkalaemia arises due to a diminished
ability to excrete potassium. Marked hyperkaelaemia is potentially life
threatening causing bradycardia and cardiac arrest.
| ELEVATED LEVELS | LOW LEVELS |
| Hyperkalaemia | Hypokalaemia |
| Acute renal failure | Diuretic therapy |
| Hypoadrenocorticism | Diabetes mellitus |
| Iatrogenic (KCl) | Polyuric disorders |
| Massive tissue damage | Vomiting and diarrhoea |
| Metabolic acidosis (e.g. liver failure) | Chronic renal failure (particularly cats) |
| Low sodium intake | Insulin therapy |
| Urethral obstruction | Steroid administration |
| Drug action (e.g. digitalis) | Excessive bicarbonate therapy |
| Bladder rupture | Administration of potassium depleted fluids |
| Diabetes mellitus | Excessive mineralocorticoid therapy |
| Chronic renal failure (terminal event) | |
| Chronic hepatic disease | |
| Thrombocytosis | |
| Hyperadrenocorticism | |
| Acute renal failure (polyuric phase) | |
| Fanconi's syndrome | |
| Alkalosis (respiratory or metabolic) | |
| Hypothermia | |
| Hypomagnesaemia |
COMPLEMENTARY TESTS
In small animals a sodium:potassium ratio is useful information for an aid to the diagnosis of hypoadrenocorticism; a ratio of <27:1 is suspicious, <25:1 is suggestive. An ACTH stimulation test should be considered for confirmation.
Equine
| Reference Range | Equine | 2.7 - 5.9 mmol/L/l |
Potassium levels in the extracellular
fluid are influenced most by renal function and do not always reflect potassium
levels in the intracellular compartment. Potassium distribution depends
on the acid-base status as it is exchanged for hydrogen ions across the
cell membrane. Hyperkalaemia is a potential emergency due to induction
of cardiac dysrrythmias.
| ELEVATED LEVELS | LOW LEVELS |
| Hyperkalaemia | Hypokalaemia |
| Reduced extra-cellular fluid volume | Reduced intake |
| AnaemiaHaemolysis | Gastrointestinal tract loss ( lower bowel obstruction) |
| Muscle damageAnaemia | Polyuric conditions including renalenal failure |
| HypoadrenocorticismMuscle damage | Alkalosis |
| Anuric renal failure Hypoadrenocorticism | Enterocolitis |
| Urinary tract disruption Anuric renal failure | Anorexia |
| Urinary tract disruption | Renal tubular acidosis |
| Iatrogenic (diuretics, bicarbonate or insulin administration) |
COMPLEMENTARY TESTS
In equines the calculation of urine
clearance ratios will assist interpretation of serum electrolyte and mineral
levels.
Top
Serum proteins vary widely in their size, structure and function. Abnormal levels of these proteins are termed dysproteinaemias. Total protein and albumin concentrations are determined and the globulin concentration arrived at by subtraction. Total protein levels are affected by physiological as well as pathological factors. Total protein levels are low in neonates rising to adult levels by 6 months to 1 year of age. In older animals total protein levels are high due mainly to IgG synthesis. Serum total protein levels are approximately 5% less than those of plasma due to the loss of fibrinogen in the clotting process.
Small Animals
|
|
|
|
| Total Protein | 55 - 75 g/L/l | 55 - 78 g/L/l |
| Albumin | 31 - 40 g/L/l | 26 - 40 g/L/l |
| Globulin | 18 - 38 g/L/l | 19 - 48 g/L/l |
| ELEVATED LEVELS | LOW LEVELS |
| Hyperalbuminaemia | Hypoalbuminaemia |
| Dehydration | Hepatic insufficiency |
| Protein losing enteropathy | |
| Hyperglobulinaemia | Protein losing nephropathy |
| ImmuneImmmune response | Haemorrhage |
| Infection | Protein malnutrition/ malabsorption |
| Inflammation | Trauma |
| Neoplasia | Exudation |
| Immune mediated disorders | Sepsis |
| Compensatory for hypoalbuminaemia | Congestive heart failure |
| Compensatory for a hyperglobulinaemia | |
| Hypoglobulinaemia | |
| Haemorrhage | |
| Protein losing enteropathy | |
| Congenital immunodeficiency | |
| Neonates |
COMPLEMENTARY TESTS
Serum Pprotein electrophoresis (hyperglobulinaemia). Urine protein electrophoresis. Radial immunodiffusion for IgG, IgA and IgM (canine) (suspected immunodeficiency and classification of myelomas).
Equine
|
|
|
| Total protein | 60 - 80 g/L/l |
| Albumin | 27 - 40 g/L/l |
| Globulin | 17 - 34 g/L/l |
| ELEVATED LEVELS | LOW LEVELS |
| Hyperalbuminaemia | Hypoalbuminaemia |
| Dehydration | Advanced hepatic insufficiency |
| Protein losing enteropathy | |
| Hyperglobulinaemia | Protein losing nephropathy |
| Infection | Endoparasitism |
| Inflammation | Chronic infection |
| Neoplasia | Neoplasia |
| Immune response Hyperglobulinaemia | Trauma |
| Compensatory for a hypoalbuminaemia | Haemorrhage |
| Compensatory for a hyperglobulinaemia | |
| Hyperglobulinaemia | Hypoglobulinaemia |
| Infection | Inadequate transfer of colosterum (neonates) |
COMPLEMENTARY TESTS
Protein electrophoresis (hyperglobulinaemia)
Top
The distribution of sodium in the body differs from that of potassium. Sodium is predominantly extracellular due to the sodium pump mechanism. In contrast, only 2% of potassium is extracellular, the rest being intracellular. Renal function is the single most important homeostatic mechanism in relation to plasma concentrations of sodium and potassium.
Small Animals
| Reference Ranges | Canine | 135-150 mmol/L/l | Feline | 141-155 mmol/L/l |
Slight hyponatraemia is common in small
animals. Marked hyponatraemia or a sodium:potassium ratio < 27:1 indicates
further investigation. Marked hyponatraemia may cause fluid movement into
cells with an effect on neurological function. Hypernatraemia is uncommon
in small animals. It almost always indicates water intake which is inadequate
to balance fluid losses. Marked hypernatraemia may lead to neurological
signs due to the net movement of water out of the cells.
| ELEVATED LEVELS | LOW LEVELS |
| Hypernatraemia | Hyponatraemia |
| Diabetes mellitus | Hypoadrenocorticism |
| Diabetes insipidus | Severe dehydration (vomiting and diarrhoea) |
| Insensible losses | Diabetes mellitus |
| Hyperadrenocorticism | Ruptured urinary tract |
| Increased sodium intake | Administration of low sodium fluids |
| Moderate dehydration | End stage chronic renal failure |
| Pyometra | Diuretic therapy |
| High protein diets | Psychogenic polydipsia |
| Osmotic diuresis | Acute renal failure (polyuric phase) |
| Osmotic cathartics | Hypertension (congestive heart failure) |
| Water restriction | Hypoalbuminaemia |
| Extreme exercise | Drug therapy (e.g. NSAID's) |
| Drug therapy (e.g. corticosteroids) | Osmotic diuresis |
| Severe hypokalaemia |
COMPLEMENTARY TESTS
In small animals a sodium:potassium ratio is useful as an aid to the information for the diagnosis of hypoadrenocorticism; a ratio of <27:1 is suspicious, <25:1 is suggestive. An ACTH stimulation test should be considered for confirmation.
Equine
| Reference Range | Equine | 133 - 143 mmol/L/l |
Sodium levels reflect the relative
amounts of water and electrolytes in the extra-cellular fluid . It is the
principle determinant of ECF volume. Hyponatraemia occurs more commonly
due to excessive losses than to reduced intake. Hypernatraemia indicates
water loss in excess of electrolytes.
| ELEVATED LEVELS | LOW LEVELS |
| Hypernatraemia | Hyponatraemia. |
| Dehydration | Gastrointestinal loss (especially high obstruction) |
| Excess saline therapy | Chronic renal disease (PU/PD) |
| Enterocolitis | Oesophageal obstruction. |
| Excessive sweating | Enterocolitis |
| Water deprivation | Urinary tract disruption |
| Inappropriate ADH secretion. |
COMPLEMENTARY TESTS
In equines the calculation of urine
clearance ratios will assist interpretation of serum electrolyte and mineral
levels.
Top
Triglycerides may be ingested or synthesised in the liver. They are complexed with cholesterol, phospholipids and plasma proteins to form lipoproteins.
Small Animals
| Reference Ranges | Canine | 0.6 - 1.2 mmol/L/l | Feline | 0.6 - 1.2 mmol/L/l |
Triglycerides are the main constituent both of chylomicrons and very low density lipoproteins (VLDL's) which are responsible for the gross lipaemia often seen in serum or plasma samples. Chylomicrons separate and form a fatty layer after overnight refrigeration whilst VLVDL's remain dispersed in the serum/plasma. Where a sample is lipaemic after a 16 hour fast then a pathological lipaemia is said to exist.
ELEVATED LEVELS
Cholesterol (hyperlipidaemia). TRH stimulation test (hypothyroidism). ACTH stimulation test or low dose dexamethasone screening test (hyperadrenocorticism). Glucose/fructosamine (diabetes mellitus). Amylase and lipase (pancreatitis). Urine protein:creatinine ratio and albumin (nephrotic syndrome).
Equine
| Reference Range : | Equine | 0 - 0.6<0.57 mmol/L/l |
ELEVATED LEVELS
Bile acids (hepatic function). Urea
and creatinine (renal function).
Top
Urea is principally a product of amino acid deamination in the liver. Urea is primarily excreted by the kidneys and is the most commonly used test of renal function.
Small Animals
| Reference rRanges | Canine | 3.5 - 7.0 mmol/L/l | Feline | 3.5 - 8.0 mmol/L/l |
| ELEVATED LEVELS | LOW LEVELS |
| Renal Azotaemia | Polydipsia/ polyuria |
| Acute renal failure | Hepatic insufficiency |
| Chronic renal failure | Protein malnutrition |
| Prerenal Azotaemia. | Overhydration |
| Dehydration | Late pregnancy |
| Shock | Portosystemic shunt |
| High protein diet | Anabolic steroids |
| Fever | |
| Reduced cardiac output | |
| Hyperthyroidism (cats) | |
| Hypoadrenocorticism | |
| Gastrointestinal haemorrhage | |
| Prolonged exercise | |
| Glutacorticoid Corticosteroid therapy | |
| Postrrenal Azotaemia | |
| Feline urological syndrome | |
| Bladder rupture | |
| Calculi | |
| Neoplasia | |
| Perineal herniation | |
| Prostatic enlargement |
COMPLEMENTARY TESTS
Creatinine and phosphorus (azotaemia). Urine specific gravity (azotaemia); pre renal azotaemia 1.030 (dog) and 1.035 (cat), renal azotaemia 1.008 - 1.030 (dog) and 1.008 - 1.035 (cat), post renal azotaemia any value (dog and cat).
Equine
| Reference Range | Equine | 3.5 - 7.3 mmol/L/l |
| ELEVATED LEVELS | LOW LEVELS |
| Renal Azotaemia | Hepatic insufficiency |
| Acute renal failure | Young foals (normal by 60 days) |
| Chronic renal failure |
| Prerenal Azotaemia | |
| Dehydration | |
| Excessive muscle catabolism | |
| High protein diet | |
| Postrenal Azotaemia | |
| Grass sickness | |
| Obstruction | |
| Neonatal foals |
COMPLEMENTARY TESTS
Creatinine and phopsphorus (azotaemia).
Urine specific gravity (<1.020 in a dehydrated or azotaemic horse suggests
renal tubular dysfunction). Urine clearance ratios (renal tubular dysfunction).
Urinalysis;. Urinary indices for urea and creatinine given by ; urine urea
conc./serum urea conc. and urine creatinine conc./serum creatinine conc.
Prerenal azotaemia; urea index 14, creatinine index 50, renal azotaemia;
urea index <15, creatinine index <37.
Top
Equine
|
|
|
| Sodium | 0.02 - 1.0 % |
| Potassium | 15 - 65 % |
| Phosphorus | 0 - 0.5 % |
| Chloride | 0.04 - 1.6 % |
Urine clearance ratios measure the clearance of electrolytes and minerals from the plasma against that of creatinine. Creatine is selected as it is neither secreted or resorbed by the renal tubules and compares favourably with the use of endogenous substances such as inulin. Creatinine and electrolyte/mineral concentrations are measured on both urine and serum/plasma and the results are expressed as a % clearance ratio.
ELEVATED LEVELS
SMALL ANIMAL CLINICAL BIOCHEMISTRY.
Blaxter,A. (1987). Diagnosis and management of hepatic disorders in the cat. In Practice. 9 (5). p 178 - 185.
Bruijne,J.J. and Rothuizer,J. (1988). The Value of Serum Bile Acid and GLDH in the Screening for Canine Liver Function Disorders. In: Animal Clinical Biochemistry - the Future. Ed. Blackmore, D.J. Cambridge University Press. Cambridge. p 175 - 180.
Bush,B.M.(1991). Interpretation of Laboratory Results for Small Animal Clinicians. Blackwell Scientific Publications. Oxford.
Dunn,J.(1992). Assessment of liver damage and dysfunction. In Practice. 14 (4). p 193 - 200.
Evans,R.J. (1988). Hepatobiliary Damage and Dysfunction ; a Critical Overview. In: Animal Clinical Biochemistry - the Future. Ed. Blackmore, D.J. Cambridge University Press. Cambridge. p 117 - 150.
Meyer,D.J. and Carter,S.A.(1986). Approach to the diagnosis of liver disorders in dogs and cats. Comp. Contin. Educ. Pract. Vet. Small Animal. 8 (12). p 880 - 888.
Simpson,K. and Lamb, L.(1995). Acute pancreatitis in the dog. In Practice. 17 (7). p 328 - 337.
Small Animal Clinical Diagnosis by Laboratory Methods (198994). 2nd Edition, Eds. Willard,M.D.,Tvedten,H. and Turnwald,G.H. W.B.Saunders Company. Philadelphia.
Watson,T.D.G.(1993). Why is this sample lipaemic? Canine Practice. 18 (5). p 26 - 31.
Watson,T.D.G.(1994). Hyperlipidaemia in cats. The Journal of the Feline Advisory Bureau. 31 (3). p 111 - 114.
EQUINE CLINICAL BIOCHEMISTRY.
Blackmore,D.J. and Brobst,D. (1981). Biochemical Values in Equine Medicine. The Animal Health Trust. Newmarket.
Milne,E.M. (1990). Differential diagnosis of hepatic disorders in horses. In Practice. 12 (6). p 252 - 258.
Traver, D.S. et al. (1976). Urine clearance ratios as a diagnostic aid in equine metabolic disease. Proc. 22nd. A. Conv.Am.Assoc.Eq.Pract. p 177 - 183.
The Equine Manual. (1995). Eds. Higgins,A.J. and Wright, I.M. W.B.Saunders Co. Ltd. London.
Watson,T.D.G.(1994). Hyperlipaemia in ponies. In Practice. 16 (5). p 267 - 272.